Diltiazem Hydrochloride 24 HR Diltiazem Hydrochloride 180 MG Extended Release Oral Capsule

INDICATIONS AND USAGE Hypertension Diltiazem hydrochloride extended-release capsules, USP are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Chronic Stable Angina Diltiazem hydrochloride extended-release capsules, USP are indicated for the treatment of chronic stable angina.

Sandoz Inc

FDA Reported Adverse Reactions
`[1] nausea` `[2] drug ineffective` `[3] diarrhoea` `[4] off label use` `[5] fatigue` `[6] vomiting` `[7] pyrexia` `[8] dyspnoea` `[9] acute kidney injury` `[10] headache`

8 years ago

OVAL WHITE 1113

8 years ago

1113 OVAL WHITE

HOW SUPPLIED Diltiazem hydrochloride extended-release capsules, USP are available as follows: 120 mg – gray opaque cap and white opaque body printed with and “1112”on both the cap and body in black ink supplied in bottles of 30 (NDC 0781-2452-31) and bottles of 90 (NDC 0781-2452-92) with a child-resistant closure, and bottles of 500 (NDC 0781-2452-05) without a child-resistant closure. 180 mg – white opaque cap and body printed with and “1113”on both the cap and body in black ink supplied in bottles of 30 (NDC 0781-2453-31) and bottles of 90 (NDC 0781-2453-92) with a child-resistant closure, and bottles of 500 (NDC 0781-2453-05) without a child-resistant closure. 240 mg – white opaque cap and blue opaque body printed with and “1114”on both the cap and body in black ink supplied in bottles of 30 (NDC 0781-2454-31) and bottles of 90 (NDC 0781-2454-92) with a child-resistant closure, and bottles of 500 (NDC 0781-2454-05) without a child-resistant closure. 300 mg – blue opaque cap and body printed with and “1115”on both the cap and body in black ink supplied in bottles of 30 (NDC 0781-2455-31) and bottles of 90 (NDC 0781-2455-92) with a child-resistant closure, and bottles of 500 (NDC 0781-2455-05) without a child-resistant closure. 360 mg – blue opaque cap and gray opaque body printed with and “1116”on both the cap and body in black ink supplied in bottles of 30 (NDC 0781-2456-31) and bottles of 90 (NDC 0781-2456-92) with a child-resistant closure, and bottles of 500 (NDC 0781-2456-05) without a child-resistant closure. 420 mg – gray opaque cap and body printed with and “1117”on both the cap and body in black ink supplied in bottles of 30 (NDC 0781-2457-31) and bottles of 90 (NDC 0781-2457-92) with a child-resistant closure, and bottles of 500 (NDC 0781-2457-05) without a child-resistant closure. Store at 25ºC (77ºF); excursions permitted to 15 to 30ºC (59 to 86ºF) [see USP Controlled Room Temperature]. Avoid excessive humidity. Actavis Symbol Actavis Symbol Actavis Symbol Actavis Symbol Actavis Symbol Actavis Symbol

More pills like OVAL 1113

Related Pills

tizanidine 6 MG Oral Capsule

Zydus Pharmaceuticals (USA) Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site